← Leaderboards
Hugh O McDevitt
Stanford University
$2,526,799
Attributed
$2,526,799
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$5,158,257 · 5
By mechanism
P01$2,770,861 · 2
R01$1,300,702 · 1
T32$1,076,814 · 1
P41$9,880 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Seung K Kim$34,748,747
- Paul Joseph Utz$20,350,048
- William H Robinson$16,848,609
- Charles Garrison Fathman$27,441,596
- Samuel Strober$36,157,957
Others in their field
Top investigators on “Genetically Modified Animals”
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$42,971,897
- C Ronald Kahn · Joslin Diabetes Center$28,941,790
- Edward E Partridge · University Of Alabama At Birmingham$26,712,465
- Ronald B Corley · Boston University Medical Campus$26,592,975
- John T Potts · Massachusetts General Hospital$25,176,515
- Reisa A. Sperling · Banner Health$24,903,674
Research focus
Genetically Modified AnimalsNod MouseInsulin Dependent Diabetes MellitusDisease /Disorder EtiologyImmunoregulationTumor Necrosis Factor AlphaCytokine ReceptorsLaboratory MouseDevelopmental ImmunologyWestern BlottingsBiological ProductsBiological Signal TransductionBiomedical ResourceDisease /Disorder Prevention /ControlGene ExpressionGlutamate DehydrogenaseImmunologyInsulinMhc Class Ii AntigenMicroarray TechnologyPancreatic IsletsSpectrometryStructural BiologyT Cell Receptor
Grant awards (15)
Developmental &Immunoregulatory Effects of TNF$327,130
R01 · FY2004 · DK
Developmental &Immunoregulatory Effects of TNF$326,856
R01 · FY2003 · DK
MOLECULAR AND CELLULAR IMMUNOBIOLOGY$1,076,814
T32 · FY2002 · AI
PATHOGENESIS AND PREVENTION OF IDDM$898,108
P01 · FY2002 · DK
Developmental &Immunoregulatory Effects of TNF$316,197
R01 · FY2002 · DK
DEVELOPMENTAL &IMMUNOREGULATORY EFFECTS OF TNFA LTA LTB$66,760
R01 · FY2002 · DK
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$0
P01 · FY2002 · DK
INTERACTIONS OF PEPTIDES W/ CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES$0
P41 · FY2002 · RR
PATHOGENESIS AND PREVENTION OF IDDM$876,956
P01 · FY2001 · DK
INTERACTIONS OF PEPTIDES W/ CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES$0
P41 · FY2001 · RR
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$0
P01 · FY2001 · DK
PATHOGENESIS AND PREVENTION OF IDDM$856,394
P01 · FY2000 · DK
DEVELOPMENTAL &IMMUNOREGULATORY EFFECTS OF TNFA LTA LTB$263,759
R01 · FY2000 · DK
PATHOGENESIS AND PREVENTION OF TYPE I DIABETES IN THE NOD MOUSE AND MAN$139,403
P01 · FY2000 · DK
INTERACTIONS OF PEPTIDES W/ CLASS II MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULES$9,880
P41 · FY2000 · RR